Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AQST
#2746
Aquestive Therapeutics, Inc. - Common Stock
4.6
7
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.91%
Monthly Change
-3.11%
6 month change
+12.53%
Year Change
-32.90%
Previous Close
4.8
1
Open
4.8
0
Low
4.6
7
High
4.8
1
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
AQST
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2018
Current report, 27 Jul 2018
2018.07.27
Aquestive Therapeutics, Inc. current report, 27 July 2018
8-K
Quarterly report, Q2 FY2018
2018.09.04
Aquestive Therapeutics, Inc. quarterly report, Q2 FY2018
10-Q
1
...
15
16
17
18
19
20
21
22
News
Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success (NASDAQ:AQST)
Aquestive Therapeutics Resubmits FDA Application for Pocket-Sized Allergy Treatment
Aquestive Therapeutics, Inc. (AQST) Q2 2026 Earnings Call Transcript
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates
Xencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock?
Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?
Aquestive Therapeutics: Rating Downgrade Despite Probability Of Anaphylm Approval
Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right (NASDAQ:XERS)
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates